HRI vs AHCO

For growth investors, Herc Holdings Inc.

(HRI) is the stronger pick with 22. 6% revenue growth year-over-year, versus -0. 5% for AdaptHealth Corp. (AHCO). Herc Holdings Inc. (HRI) offers the better valuation at 4123. 8x trailing P/E (22. 1x forward), making it the more compelling value choice. Analysts rate Herc Holdings Inc. (HRI) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, AdaptHealth Corp.

is actually cheaper at 11. 7x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Herc Holdings Inc.

(HRI) delivered a total return of +27. 2%, compared to -55. 5% for AdaptHealth Corp. (AHCO). Over 10 years, the gap is even starker: HRI returned +445. 9% versus AHCO's +20. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), AdaptHealth Corp.

(AHCO) is the lower-risk stock at 0. 83β versus Herc Holdings Inc. 's 2. 02β — meaning HRI is approximately 144% more volatile than AHCO relative to the S&P 500. On balance sheet safety, AdaptHealth Corp. (AHCO) carries a lower debt/equity ratio of 125% versus 6% for Herc Holdings Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Herc Holdings Inc.

(HRI) is pulling ahead at 22. 6% versus -0. 5% for AdaptHealth Corp. (AHCO). On earnings-per-share growth, the picture is similar: Herc Holdings Inc. grew EPS -99. 6% year-over-year, compared to -185. 2% for AdaptHealth Corp.. Over a 3-year CAGR, HRI leads at 16. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Herc Holdings Inc.

(HRI) is the more profitable company, earning 0. 0% net margin versus -2. 2% for AdaptHealth Corp. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HRI leads at 15. 3% versus 5. 7% for AHCO. At the gross margin level — before operating expenses — HRI leads at 28. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, AdaptHealth Corp.

(AHCO) trades at 11. 7x forward P/E versus 22. 1x for Herc Holdings Inc. — 10. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HRI: 39. 0% to $183. 40.

In this comparison, HRI (2.

1% yield) pays a dividend. AHCO does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, AdaptHealth Corp.

(AHCO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 83)). Herc Holdings Inc. (HRI) carries a higher beta of 2. 02 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AHCO: +20. 9%, HRI: +445. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HRI (Industrials) and AHCO (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HRI is a small-cap high-growth stock; AHCO is a small-cap quality compounder stock. HRI pays a dividend while AHCO does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.